Recommendations for a comprehensive healthcare response

Original/alternative title: 
COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper
Summary information for this document is not currently available.

Abstract

This abstract is provided here as a convenience only. Check the publisher's website (if available) for the definitive version.

Coronavirus disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).

Category: 
Scientific article
Date: 
9 April 2020  (approximate)
Location: 
Tehran
Access: 
Open access
Publisher: 
Iran University of Medical Sciences
Geographical scope: 
World
Journal: 
Basic and Clinical Neuroscience
11, 2, p.129-146, 2020
Authors: 
Ali Farhoudian, Alexander Baldacchino, Nicolas Clark, Gilberto Gerra, Hamed Ekhtiari, Geert Dom, Azarakhsh Mokri, Mandana Sadeghi, Pardis Nematollahi, Maryanne Demasi, Christian G. Schütz, Seyed Mohammadreza Hashemian, Payam Tabarsi, Susanna Galea-singer, Giuseppe Carrà, Thomas Clausen, Christos Kouimtsidis, Serenella Tolomeo, Seyed Ramin Radfar, Emran Mohammad Razaghi
Publisher's DOI: 
10.32598/bcn.11.covid19.1
Document language: 
English
Loading